The Food and Drug Administration (FDA) posted an Adderall shortage this week, warning that manufacturers will not be able to meet the U.S. market demand at the current rate of production. While several manufacturers are still producing and supplying Adderall, major pharmaceutical companies are currently dealing with issues affecting their production, said the FDA in its notice. Adderall — or mixed amphetamine salts — is a popular drug commonly prescribed for ADHD and narcolepsy. The FDA said in its notice that "alternative therapies" for these conditions were available and advised that patients speak with a health care professional on what the best treatment plan would be. Teva Pha
Hence then, the article about fda warns of adderall shortage was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA warns of Adderall shortage )